Tag Archives: TXNIP

Large-scale study identifies an epigenetic marker for Type 2 diabetes.

Type 2 diabetes is a chronic illness characterised by the presence of elevated blood glucose levels. It accounts for between 80 and 90% of diabetes cases and is one of the major cardiovascular risk factors. If not treated appropriately it can lead to very serious complications including strokes, heart attacks, neuropathy and blindness.  Currently, glycated hemoglobin A1c is used as

Read more